AbbVie Inc. (ABBV)

Exchange: New York Stock Exchange
Currency: USD

Price: 70.51 (Close)



52 Week range 200d Moving Avg. Beta
62.66 – 96.60 77.79 0.89
Dividend Dividend Yield Ex-Dividend date
4.17 5.91% 2019-10-14
P/E Ratio Latest EPS Latest EPS Date
25.87 3.68 2018-12-31
Dividend Aristocrat


AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.


Sector: Industry:
Health Technology Pharmaceuticals: Major

Dividend aristocrats in the same sector are:
– Cardinal Health Inc. (CAH)
– Abbott Laboratories (ABT)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)

AbbVie Inc. (ABBV) Performance

The chart below displays the total price return(%) of AbbVie Inc. for different periods:


AbbVie Inc. (ABBV) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of AbbVie Inc. for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
5.91 4.17 113.32% 5 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 21.13%
5 Year Growth Rate (CAGR) 17.54%
10 Year Growth Rate (CAGR) 0.00%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2019 3.210 -%
2018 3.590 40.2%
2017 2.560 12.3%
2016 2.280 12.9%
2015 2.020 21.7%
2014 1.660 3.8%
2013 1.600 0.0%

AbbVie Inc. (ABBV) Dividend Payment History